US$ 27.15
glp-1 and anxiety The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy Now, new research suggests that
Description
For years, any one trying this
10.1016/j.freeradbiomed.2021.09.006 Free Radic

To explain, lets learn some physiology first

Only one study included in the review used a validated 24-h dietary recall method

Weight regain often occurs once GLP-1 medications are stopped but OPTAVIA equips individuals with strategies and support to help keep the weight off 1,3*

The FDA also encourages healthcare providers and patients to report any adverse effects from GLP-1 and other medications
